The Emerging Role of 5-Fluorouracil and Leucovorin in the Treatment of Advanced Breast Cancer. A Review

References

• Garewal HS. Mitomycin C in the chemotherapy of advanced breast cancer. Semin Oncol 1988; 15: 74–9.
   Google Scholar
• Henderson IC, Hayes DF, Come S. New medical treatments for advanced breast cancer. Semin Oncol 1987; 14: 34-64.
   Google Scholar
• Hoogstraten B, Fabian C. A reappraisal of single drugs in advanced breast cancer. Cancer Clin Trials 1979; 2: 101–9.
   Google Scholar
• Rustum YM. Selective modulation of 5-Fluorouracil action in patients with colorectal carcinoma. Chemioterapia 1985; 4: 377–82.
   Google Scholar
• Yin MB, Zakrewski SF, Hakala MT et al. Relationship of cellular folate cofactor pools to the activity of 5-Fluorouracil. Molec Pharmacol 1983; 23: 190–7.
   Google Scholar
• Waxman S, Brukner H. The enhancement of 5-Fluorouracil antimetabolic activity by Leucovorin, menadione and α-tocopherol. Eur J Cancer Clin Oncol 1982; 18: 685–92.
   Google Scholar
• Grem JL, Noth DF, Hamilton JM et al. Overview of current status and future direction of clinical trials with 5-Fluorouracil in combination with folinic acid. Cancer Treat Rep 1987; 71: 1249–64.
   Google Scholar
• Pinedo HM, Peters GJ. Fluorouracil: biochemistry and pharmacology. J Clin Oncol 1988; 6: 1653–64.
   Google Scholar
• Arbuck SG. Overview of clinical trials using 5-Fluorouracil and Leucovorin for the treatment of colorectal cancer. Cancer 1989; 63: 1036–44.
   Google Scholar
• Machover D, Schwarzenberg L, Goldschmidt E et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high dose folinic acid: a pilot study. Cancer Treat Rep 1982; 66: 1803–7.
   Google Scholar
• Marini G, Marpicati P, Zaniboni A et al. Treatment of advanced breast cancer with 5-Fluorouracil and high dose folinic acid: preliminary results. Chemioterapia 1985; 4: 135–8.
   Google Scholar
• WHO Handbook for reporting results of cancer treatment. WHO offset publication n° 48 (WHO, Geneva, 1979).
   Google Scholar
• Marini G, Simoncini E, Zaniboni A et al. 5-Fluorouracil and high dose folinic acid as salvage treatment of advanced breast cancer: an update. Oncology 1987; 44: 336–40.
   Google Scholar
• Marini G, Simoncini E, Marpicati P et al. Premarin priming before prednimustine, high dose folinic acid and 5-Fluorouracil as salvage chemotherapy for advanced breast cancer. Chemioterapia 1988; 7: 130–2.
   Google Scholar
• Zaniboni A, Simoncini E, Marpicati P et al. Cyclophosphamide, Epirubicin, high dose folinic acid and 5-Fluorouracil as first-line chemotherapy in metastatic breast cancer. Preliminary results. Proc Am Soc Clin Oncol 1988; 7: 68.
   Google Scholar
• Zaniboni A, Simoncini E, Marpicati P et al. Cyclophosphamide, Epirubicin, High-dose folinic acid and 5-Fluorouracil (SUPER-FEC) as first-line chemotherapy for advanced breast cancer: preliminary results. Eur J Cancer Clin Oncol 1989; 24: 1151–5.
   Google Scholar
• Allegra CJ, Chabner BA, Sholar PW et al. Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-Fluorouracil and Leucovorin. NCI Monogr 1987; 5: 199–202.
   Google Scholar
• Swain SM, Lippman ME, Chabner BA et al. Salvage treatment of patients with metastatic breast cancer with 5-Fluorouracil and high-dose leucovorin. Proc Am Soc Clin Oncol 1988; 7: 58.
   Google Scholar
• Doroshow JH, Leong L, Margolin K et al. Refractory metastatic breast cancer: salvage therapy with Fluorouracil and high-dose continuous infusion Leucovorin calcium. J Clin Oncol 1989; 7: 439–44.
   Google Scholar
• Di Biasio B, Bella M, Bisagni G et al. Tre consecutive esperienze di fase I-II con la combinazione di acido folinico (AF) e 5-Fluorouracile (5-FU) in pazienti con tumori solidi avanzati. Atti IV Riunione Naz. Oncol. Sper. Clin, Bari 15–17 Dicembre 1986, abst. n. 205.
   Google Scholar
• Loprinzi CL. 5-Fluorouracil with Leucovorin in breast cancer. Cancer 1989; 63: 1045–7.
   Google Scholar
• Jabboury K, Holmes F, Hortobagyi G et al. Folinic acid modulation of low-dose fluorouracil infusion in refractory breast cancer. A preliminary report. Breast Cancer Res Treat 1988, 12: 124.
   Google Scholar
• Adamo V, Altavilla G, Caristi N et al. Acido folinico ad alte dosi e 5-FU nel trattamento dei carcinomi metastatizzati del colon retto e della mammella. Atti IV Riunione Naz. Oncol. Sper. Clin, Bari, 15–17 Dicembre 1986, abst.n° 119.
   Google Scholar
• Becher R, Kurschel E, Hofeler H et al. Phase II study with 5-Formyltetrahydrofolate and 5-Fluorouracil. In: Rustum YM, McGuire JJ, eds. The expanding role of folates and fluoropyrimidines in cancer chemotherapy. New York: Plenum, 1988 (in press).
   Google Scholar
• Fine S, Erlichman C, Kaizer L et al. Phase II trial of 5-FU + folinic acid as firstline treatment for metastatic breast cancer. Proc Am Soc Clin Oncol 1988; 7: 41.
   Google Scholar
• Bruckner HW. Comments on the use of leukovorin as a potentiatior of 5-Fluorouracil. Cancer Invest 1988; 6: 233–4.
   Google Scholar
• Grem JL, Shoemaker DD, Petrelli NJ et al. Severe and fatal toxic effects observed in treatment with high and low-dose leucovorin plus 5-Fluorouracil in colorectal carcinoma. Cancer Treat Rep 1987; 711: 1122.
   Google Scholar
• Clark PI, Slevin MI. Allopurinol mouthwashes and 5-Fluorouracil induced oral toxicity. Eur J Surg Oncol 1985; 11: 267–8.
   Google Scholar
• Scholnik AP, Arnold DJ, Walker WS et al. High-dose folinic acid and 5-Fluorouracil in the treatment of advanced colon cancer. Am J Clin Oncol (CCT) 1988; 11: 558–63.
   Google Scholar
• Spears CP, Gustavsson BG, Berne M et al. Mechanisms of innate resistance to thymidylatesynthase inhibition after 5-Fluorouracil. Cancer Res 1988; 48: 5894–5900.
   Google Scholar
• Vokes EE, Choi KE, Schilsky RL et al. Cisplatin, 5-Fluorouracil and high-dose leucovorin for recurrent or metastatic head and neck cancer. J Clin Oncol 1988; 6: 618–22.
   Google Scholar
• Grem JL, Fisher PH. Augmentation of 5-Fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Cancer Res 1985; 45: 2967–72.
   Google Scholar
• Grem JL, King SA, O'Dwyer PJ et al. Biochemistry and clinical activity of N-(Phosphonacety-L- Aspar tate): a review. Cancer Res 1988; 48: 4441–54.
   Google Scholar
• Ardolan B, Chandrasekaran B. Biological mechanisms for the scheduled synergism of (αS, 5S)-α-amino3chloro-4,6-dihydro-5isoxazoleacetic acid and 5-Fluorouracil in P388 leukemia. Cancer Chemother Pharmacol 1985; 15: 44–8.
   Google Scholar